ArticlePhencyclidine and the midbrain dopamine system: Electrophysiology and behavior
References (51)
- et al.
Phencyclidine self-administration in the Rhesus monkey
Pharmacol. Biochem. Behav.
(1973) - et al.
Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex
Life Sci.
(1989) - et al.
Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs
Pharm. Biochem. Behav.
(1989) - et al.
CPP, a new potent and selective NMDA antagonist
Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity
Brain Res.
(1986) - et al.
The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity
Eur. J. Pharmacol.
(1984) Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat
Neuropharmacol
(1986)Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates
Neuropharmacol
(1988)Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons
Eur. J. Pharmacol.
(1992)- et al.
Noncompetitive antagonists are potent activators of ventral tegmental A10 dopamine neurons
Neurosci. Lett.
(1990) - et al.
Effects of competitive antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine
Neuropharmacol
(1991)
Bimodal effects of phencyclidine on A10 dopamine neurons results from diverse actions at the PCP-receptor and dopamine uptake complex
Eur. J. Pharmacol.
(1990)
Phasic vs. tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
Neurosci.
(1991)
Ketamine and phencyclidine cause a voltage-dependent block of response to L-aspartic acid
Neurosci. Lett.
(1985)
Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding
Pharmacol. Biochem. Behav.
(1985)
CGS 19755 is a potent and competitive antagonist at NMDA-type receptors
Eur. J. Pharmacol.
(1988)
Mechanisms of blockade of excitatory amino acid receptor channels
Trends Pharmaocl. Sci.
(1990)
Two types of neurons in the substantia nigra pars compacta studied in a slice preparation
Neurosci. Res.
(1987)
The effects of phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity
Eur. J. Pharmacol.
(1990)
Evidence for the presence of receptors in the ventral tegmental area of the rat: An electrophysiological in vitro study
Brain Res.
(1990)
Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro
Brain Res.
(1988)
The binding of [3H]TCP to the NMDA-phencyclidine receptor complex
Neuropharmcol
(1989)
Phencyclidine suppresses the activity of midbrain dopamine-containing neurons recorded from mouse brain slices in vitro
Eur. J. Pharmacol.
(1987)
[3H]TCP: A new tool with high affinity for the PCP receptor in rat brain
Brain Res.
(1983)
[3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): A new phencyclidine analog selective for the dopamine uptake complex
Eur. J. Pharmacol.
(1988)
Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: An extracellular in vitro study
Life Sci.
(1993)
Cited by (0)
Copyright © 1994 Published by Elsevier Inc.